Matthews International Capital Management LLC acquired a new stake in shares of NextCure Inc (NASDAQ:NXTC) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 450,000 shares of the company’s stock, valued at approximately $6,741,000. Matthews International Capital Management LLC owned 2.05% of NextCure at the end of the most recent quarter.
NXTC has been the topic of a number of research reports. Zacks Investment Research cut shares of NextCure from a “hold” rating to a “sell” rating in a report on Wednesday. Bank of America initiated coverage on shares of NextCure in a report on Tuesday, July 9th. They set a “buy” rating and a $25.00 target price on the stock. Piper Jaffray Companies initiated coverage on shares of NextCure in a report on Monday, June 3rd. They set an “overweight” rating and a $26.00 target price on the stock. Finally, Morgan Stanley boosted their target price on shares of NextCure from $25.00 to $33.00 and gave the company an “overweight” rating in a report on Tuesday, August 13th.
Shares of NXTC stock traded up $0.43 during mid-day trading on Thursday, reaching $29.95. 987 shares of the company’s stock traded hands, compared to its average volume of 75,274. NextCure Inc has a 12 month low of $13.86 and a 12 month high of $29.87. The company has a current ratio of 17.05, a quick ratio of 17.05 and a debt-to-equity ratio of 0.02. The firm’s 50-day simple moving average is $20.73.
NextCure (NASDAQ:NXTC) last announced its earnings results on Monday, August 12th. The company reported ($0.61) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.46) by ($0.15). The firm had revenue of $1.40 million for the quarter, compared to analysts’ expectations of $1.50 million. On average, sell-side analysts forecast that NextCure Inc will post -1.89 earnings per share for the current fiscal year.
There is no company description available for NextCure Inc
Featured Article: What is the Difference Between Common Shares and Convertible Shares?
Want to see what other hedge funds are holding NXTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextCure Inc (NASDAQ:NXTC).
Receive News & Ratings for NextCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextCure and related companies with MarketBeat.com's FREE daily email newsletter.